Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
3-D Transcranial Ultrasound Analysis Study
This study is not yet open for participant recruitment.
Verified by Duke University, October 2005
Sponsored by: Duke University
Information provided by: Duke University
ClinicalTrials.gov Identifier: NCT00239525
  Purpose

The purpose of this study is to investigate real time 3-D ultrasound imaging of the brain for the diagnosis and evaluation of stroke.


Condition Intervention Phase
Cerebrovascular Accident, Intracranial Hypertension
Device: 3-D ultrasound scanner
Drug: Perflutren Protein-Type A Microspheres for injection
Phase I

MedlinePlus related topics: High Blood Pressure Ultrasound
Drug Information available for: Octafluoropropane
U.S. FDA Resources
Study Type: Interventional
Study Design: Diagnostic, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study

Further study details as provided by Duke University:

Estimated Enrollment: 20
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

Exclusion Criteria:

  • persons <18 years old
  • pregnant or nursing women
  • history of neurological disease
  • congenital heart defect
  • severe liver dysfunction
  • respiratory distress syndrome
  • hypersensitivity or an allergic reaction to blood products.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00239525

Contacts
Contact: Danielle R Duckworth, BSN (919)668-1429 danielle.duckworth@duke.edu

Locations
United States, North Carolina
Duke University Medical Center
Durham, North Carolina, United States, 27710
Sponsors and Collaborators
Duke University
Investigators
Principal Investigator: Daniel T Laskowitz, MD unaffiliated
  More Information

Study ID Numbers: 05-OPT-002
Study First Received: October 13, 2005
Last Updated: October 13, 2005
ClinicalTrials.gov Identifier: NCT00239525  
Health Authority: United States: Department of Health and Human Services;   United States: Office of Human Resource Protections

Study placed in the following topic categories:
Cerebral Infarction
Stroke
Pseudotumor Cerebri
Vascular Diseases
Central Nervous System Diseases
Ischemia
Brain Diseases
Cerebrovascular Disorders
Intracranial Hypertension
Pseudotumor cerebri
Brain Ischemia
Brain Infarction
Infarction
Hypertension

Additional relevant MeSH terms:
Nervous System Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 14, 2009